{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T05:27:49Z","timestamp":1783229269629,"version":"3.54.6"},"reference-count":42,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:p>\n                    <jats:italic toggle=\"yes\">Background:<\/jats:italic>\n                    Given that opioid misuse\/abuse and opioid overdose have reached epidemic proportions in the United States, expansion of naloxone access programs are desperately needed. The objective of this study was to describe emerging trends in naloxone rescue kit (NRK) prescription patterns by pharmacists in New Mexico as an example of a unique health care delivery system.\n                    <jats:italic toggle=\"yes\">Methods:<\/jats:italic>\n                    The study presents cross-sectional analysis of the data on NRK prescriptions by pharmacists who received naloxone pharmacist prescriptive authority certification since 2013. Data were obtained from the Prevention of Opioid Overdose by New Mexico Pharmacists (POINt-Rx) Registry, maintained by the University of New Mexico and the New Mexico Pharmacists Association.\n                    <jats:italic toggle=\"yes\">Results:<\/jats:italic>\n                    Since 2013, 133 NRKs prescribed by pharmacists have been reported to the POINt-Rx Registry. The mean age of the patients was 41.5 \u00b1 12.0\u00a0years (range: 19\u201367 years), and 60.2% were female participants. Only 11.3% of the prescriptions were from pharmacists practicing in rural\/mixed urban-rural areas. The majority of NRKs (89.5%) were first-time prescriptions. The most common reason for a NRK prescription was patient's request (56.4%), followed by a pharmacist's prescription of NRK due to high dose of prescription opioids (28.6%) and history of opioid misuse\/abuse (15.0%). In addition to opioids, other frequently reported substances included alcohol (9.2%) and benzodiazepines (10.8%). More than a third of patients (38.5%) reported polysubstance use in the previous 72\u00a0hours.\n                    <jats:italic toggle=\"yes\">Conclusions:<\/jats:italic>\n                    These results indicate that patients at risk of opioid overdose might feel comfortable soliciting NRKs from a pharmacist. Participation of pharmacists in rural areas in the naloxone prescriptive authority highlight the opportunity for this novel health care delivery model in underserved areas; however, the program is clearly underutilized in these areas. Such a model can provide expanded patient access in community practices, whereas systematic efforts for uptake of the program by policy makers, communities, and pharmacists continue to be needed nationwide.\n                  <\/jats:p>","DOI":"10.1080\/08897077.2016.1184739","type":"journal-article","created":{"date-parts":[[2016,5,10]],"date-time":"2016-05-10T13:48:02Z","timestamp":1462888082000},"page":"55-60","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":34,"title":["Opioid Overdose Prevention through Pharmacy-Based Naloxone Prescription Program: Innovations in Health Care Delivery"],"prefix":"10.1177","volume":"38","author":[{"given":"Amy","family":"Bachyrycz","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of New Mexico, Albuquerque, New Mexico, USA"},{"name":"Walgreens Pharmacy, Albuquerque, New Mexico, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikhar","family":"Shrestha","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of New Mexico, Albuquerque, New Mexico, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry E.","family":"Bleske","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of New Mexico, Albuquerque, New Mexico, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale","family":"Tinker","sequence":"additional","affiliation":[{"name":"New Mexico Pharmacists Association, New Mexico, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila N.","family":"Bakhireva","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of New Mexico, Albuquerque, New Mexico, USA"},{"name":"Department of Family and Community Medicine, School of Medicine, University of New Mexico, Albuquerque, New Mexico, USA"},{"name":"Division of Epidemiology and Biostatistics, Department of Internal Medicine, School of Medicine, University of New Mexico, Albuquerque, New Mexico, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2017,1,1]]},"reference":[{"key":"e_1_3_4_2_2","volume-title":"Results From the 2013 National Survey on Drug Use and Health: Summary of National Findings","author":"Substance Abuse and Mental Health Services Administration","year":"2014","unstructured":"Substance Abuse and Mental Health Services Administration. Results From the 2013 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014. NSDUH Series H-48, HHS Publication No. (SMA) 14-4863."},{"key":"e_1_3_4_3_2","unstructured":"Centers for Disease Control. Injury Prevention and Control; Prescription Drug Overdose Data. http:\/\/www.cdc.gov\/drugoverdose\/data\/overdose.html. Published 2014. Accessed February 9 2016."},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.11859"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss6409a1"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.9257"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2015.14286"},{"key":"e_1_3_4_8_2","unstructured":"Drug Facts and Comparisons\u00ae Publishing Group. Drug Facts and Comparisons\u00ae. Philadelphia PA: Wolters Kluwer Health; 2008."},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.200700143"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2015.1010032"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2005.03.007"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp130798"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02724.x"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2005.tb06550.x"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f174"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-14-261"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/jlme.12208"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.10.013"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.3109\/00952990.2015.1109648"},{"key":"e_1_3_4_20_2","volume-title":"R: A Language and Environment for Statistical Computing [computer program]","author":"R Core Team","year":"2013","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing [computer program]. Vienna, Austria: R Foundation for Statistical Computing; 2013."},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2011.01134.x"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2012.07.004"},{"issue":"189","key":"e_1_3_4_23_2","first-page":"1","article-title":"Prescription Opioid Analgesic Use Among Adults: United States, 1999\u20132012","author":"Frenk SM","year":"2015","unstructured":"Frenk SM, , Porter KS, , Paulozzi LJ. Prescription Opioid Analgesic Use Among Adults: United States, 1999\u20132012. NCHS Data Brief. 2015;(189):1\u20138.","journal-title":"NCHS Data Brief."},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1177\/1715163514552557"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12131"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091157"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1369-7625.2004.00274.x"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2015.07.011"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1331\/JAPhA.2014.14039"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.08.051"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijpp.12041"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1626"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550490802544938"},{"key":"e_1_3_4_34_2","author":"Centers For Disease Control and Prevention","year":"2014","unstructured":"Centers For Disease Control and Prevention. Prevention Status Reports 2013: Prescription Drug Overdose\u2014New Mexico. http:\/\/www.cdc.gov\/psr\/prescriptiondrug\/2013\/nm-pdo.pdf. Published 2014. Accessed November 11, 2015.","journal-title":"Prevention Status Reports 2013: Prescription Drug Overdose\u2014New Mexico"},{"key":"e_1_3_4_35_2","unstructured":"Bureau of Vital Records and Health Statistics (BVRHS) New Mexico Department of Health. New Mexico Death Data. https:\/\/ibis.health.state.nm.us\/community\/highlight\/profile\/DrugOverdoseDth.Cnty\/geocnty\/39.html. Accessed October 30 2015."},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2006.02.001"},{"key":"e_1_3_4_37_2","unstructured":"United Nations Office on Drugs and Crimes. Community Based Treatment. https:\/\/www.unodc.org\/treatment\/en\/community_based_treatment.html. Accessed October 26 2015."},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2011.01128.x"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2014.921745"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2013.793355"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1177\/1090198114529131"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1177\/1060028014523730"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1177\/0897190014522064"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2016.1184739","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2016.1184739","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2016.1184739","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:47:40Z","timestamp":1777625260000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2016.1184739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1080\/08897077.2016.1184739"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2016.1184739","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}